https://www.selleckchem.com/pr....oducts/Pyroxamide(NS
86, intraoperative blood loss (p=0.66, inpatient stay (p=0.585) and postoperative bleeding rate (p=0.245). The frequency of tracheostomy and percutaneous endoscopic gastrostomy between both groups is comparable, with a longer duration of tube feeding in patients who have received TLM (p=0.03. In conclusion, TORS allows for similar oncological outcomes compared with TLM at comparable perioperative risks. The postoperative swallowing function may benefit from TORS. In conclusion, TORS allows for similar oncological ou
إعجاب
علق
شارك
